Nurami Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • 2ndary - Open

  • Investors
  • 10

Nurami General Information

Description

Manufacturer of bioresorbable surgical implants designed for soft tissue repair. The company offers multilayer dural repair grafts, soft tissue implants, surgical sealants, cranial surgical grafts, spinal surgical grafts, and bioresorbable scaffolds, enabling neurosurgeons to prevent cerebrospinal fluid leakage and promote natural tissue regeneration through electrospun nanofiber technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972
Primary Industry
Surgical Devices
Corporate Office
  • 36 Ha-Namal Street
  • Haifa 3303203
  • Israel
+972

Nurami Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Secondary Transaction - Open Market 01-Apr-2026 Completed Generating Revenue
16. Later Stage VC 29-Jun-2025 Completed Generating Revenue
15. Grant 16-Jul-2024 Completed Generating Revenue
14. Later Stage VC 16-Jul-2024 Completed Generating Revenue
13. Accelerator/Incubator 03-Jun-2024 Completed Generating Revenue
12. Grant 01-Jan-2023 Completed Generating Revenue
11. Later Stage VC 01-Aug-2022 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Grant 01-Jan-2021 $790K $9.3M Completed Generating Revenue
8. Accelerator/Incubator $9.3M Completed Generating Revenue
To view Nurami’s complete valuation and funding history, request access »

Nurami Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B-1
Preferred B-2
Preferred A 136,088 $0.010000 $44.09 $44.09 1x $44.09 17.13%
Ordinary A 4,000,000 $0.010000 $14.63 $14.63 1x $14.63 10.98%
To view Nurami’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nurami Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of bioresorbable surgical implants designed for soft tissue repair. The company offers multilayer dural rep
Surgical Devices
Haifa, Israel
28 As of 2025

Paramus, NJ
 

Portage, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nurami Competitors (3)

One of Nurami’s 3 competitors is Regenity Biosciences, a Private Equity-Backed company based in Paramus, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenity Biosciences Private Equity-Backed Paramus, NJ
Stryker Formerly VC-backed Portage, MI
Integra LifeSciences Holdings Corporation Princeton, NJ
You’re viewing 3 of 3 competitors. Get the full list »

Nurami Patents

Nurami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190784-A1 A tissue-adhesive matrix and uses thereof Pending 11-Mar-2025
AU-2024349836-A1 A multi-layered matrix and uses thereof Pending 28-Sep-2023
EP-4784180-A1 A multi-layered matrix and uses thereof Pending 28-Sep-2023
WO-2025069037-A1 A multi-layered matrix and uses thereof Inactive 28-Sep-2023
US-20260200203-A1 Multi-layered matrix and uses thereof Pending 28-Sep-2023 B32B5/02
To view Nurami’s complete patent history, request access »

Nurami Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
MedTech Innovator Accelerator/Incubator
Arieli Group Venture Capital Minority
Almeda Ventures Venture Capital Minority
GlenRock Israel Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

Nurami FAQs

  • When was Nurami founded?

    Nurami was founded in 2014.

  • Where is Nurami headquartered?

    Nurami is headquartered in Haifa, Israel.

  • What is the size of Nurami?

    Nurami has 28 total employees.

  • What industry is Nurami in?

    Nurami’s primary industry is Surgical Devices.

  • Is Nurami a private or public company?

    Nurami is a Private company.

  • What is Nurami’s current revenue?

    The current revenue for Nurami is .

  • How much funding has Nurami raised over time?

    Nurami has raised $43.7M.

  • Who are Nurami’s investors?

    European Innovation Council, MedTech Innovator, Arieli Group, Almeda Ventures, and GlenRock Israel are 5 of 10 investors who have invested in Nurami.

  • Who are Nurami’s competitors?

    Regenity Biosciences, Stryker, and Integra LifeSciences Holdings are competitors of Nurami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process